Delcath Systems (DCTH)
(Delayed Data from NSDQ)
$8.37 USD
+0.14 (1.70%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $8.36 -0.01 (-0.12%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Brokerage Reports
Delcath Systems, Inc. [DCTH]
Reports for Purchase
Showing records 1 - 20 ( 150 total )
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Growth on the Horizon for 2024 and Beyond; New $22 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Positive HEPZATO KIT Adoption Trends Expected to Continue; New PT $20; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
3Q23 Recap - Launch Targeted for Early 2024 (No Change)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Expect HEPZATO Launch in January 2024; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Hepzato Gained FDA Approval; Potential Launch in 4Q23; New PT $18; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Preparations For Hepzato Launch Underway; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
4Q22 Recap - NDA Accepted and Balance Sheet Fortified
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
PDUFA Date for HEPZATO Set; Dilution-Led Lower PT To $17; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Filing Complete; Acceptance Decision in 30 Days
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
M-PHP Plus Checkpoint Inhibitors Shows Promise in Metastatic Uveal Melanoma; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S